Delivery Order SPE2D018D0005-SPE2D325F9812

Award Date 4/14/25
Potential Completion Date 4/17/25
Potential Value $2.9K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer. The $1,037.23 firm fixed price delivery order is for the supply of 4566514555 REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL. The ultimate completion date for this contract is November 26, 2024. Ortho-Clinical Diagnostics has provided a range of medical equipment, reagents, and testing services to federal agencies...
This is a federal contract award from the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $5,739.54 firm fixed-price delivery order is for the supply of 4567948697 REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 16, 2025. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and the contract does not utilize any set-aside...
This is a firm fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency Troop Support to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $1,037.23 contract provides 150 milliliter bottles of Reagent Anti-D Bioclone, a critical diagnostic reagent. Ortho-Clinical Diagnostics has provided a range of medical equipment, reagents, and services to various federal healthcare agencies, including the Department of...
This federal contract award with ID SPE2D018D0005|SPE2D324F9992 was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company. The $1,037.23 firm fixed price delivery order is for 4,564,682,954 units of Reagent Anti-D Bioclone, a monoclonal diagnostic reagent. The contract has an ultimate completion date of May 24, 2024. Ortho-Clinical Diagnostics, Inc. has provided medical equipment, reagents,...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency Troop Support Medical to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the provision of 150 milliliters of reagent anti-D bioclone. The contract has a potential value of $1,037.23 and a completion date of February 27, 2024. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that provides a range of diagnostic solutions, including analyzers, reagents, and...
This federal contract award to Ortho-Clinical Diagnostics, Inc., a self-certified HUBZone joint venture manufacturer, was issued by the Medical Supply Chain division of the Defense Logistics Agency. The $2,869.77 firm-fixed-price delivery order is for the supply of 150 ml bottles of Reagent Anti-D Bioclone, a critical medical reagent. The contract has an ultimate completion date of October 3, 2024. Ortho-Clinical Diagnostics has previously provided a range of medical equipment, reagents, and...
This federal contract award, with a ceiling value of $1,037.23, was issued by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company, for the provision of REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of November 25, 2024. Ortho-Clinical Diagnostics, Inc. is a for-profit organization and self-certified HUBZone joint venture that has previously...
This is a $1,037.23 firm fixed-price delivery order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the supply of 150 ml monoclonal anti-D reagent. The contract has an ultimate completion date of November 25, 2024 and does not utilize any set-aside designations. Ortho-Clinical Diagnostics is a provider of medical diagnostic solutions, including COVID-19 tests and immunodiagnostic/clinical chemistry analyzers, and...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Ortho-Clinical Diagnostics, Inc. for the delivery of 150 milliliter bottles of Reagent Anti-D Bioclone. The contract has a firm fixed price of $1,037.23 and a completion date of March 5, 2024. The contract was not set aside for any particular business type. Ortho-Clinical Diagnostics, Inc. is a for-profit medical equipment manufacturer that has provided a range of diagnostic solutions, including...
The Defense Logistics Agency Troop Support Medical awarded a $5,186.15 firm fixed price delivery order to Ortho-Clinical Diagnostics Inc. for the procurement of 150ml REAGENT ANTI-D BIOCLONE. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides a range of diagnostic solutions, including products and services to federal agencies such as the Department of Veterans Affairs and Defense Health Agency. This award was not designated as a set-aside contract. The performance...
  • SPE2D018D0005
    Indefinite Delivery Contract
  • SPE2D018D0005-SPE2D325F9812
    Delivery Order

This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the delivery of reagent anti-D bioclone 150ML monoclonal products. The contract has an award value of $2,869.77 and a completion date of April 17, 2025. The contract was awarded by the Medical Supply Chain, a component of the Defense Department. No set-aside designation was used, indicating open competition. Ortho-Clinical Diagnostics, Inc. holds several significant Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with various federal healthcare agencies, demonstrating its capability to provide complex, long-term medical diagnostic equipment and service contracts across the federal healthcare system.

Generated 7/14/25, 11:02 AM